Diabetes has become rampant in China in recent years, with nearly 50 million people infected by the disease. In order to treat the disease and ensure the public’s health, the national “863 Program” has underpinned the R&D and industrialization of “Micro Integrated Diabetes Test Systems”.
The project is coordinated by Zhejiang University, with Shanghai MicroSense TM Inc., Hangzhou Newasia Meter Equipment Factory and Ningbo David Medical Device Co., Ltd as the product manufacturers. By now, Shanghai MicroSense TM Inc. has built and put into use the largest biosensor assembly line that meets the GMP requirements in China. The improved hand-held blood glucose meter and strip are applying for the U.S. FDA license and has already passed the 1st stage authentication.